摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

R(-)-N-ethyl-2-(2-fluoroethoxy)-10-[(trifluoromethyl)sulfonyl]oxy-11-hydroxynoraporphine | 1264293-71-1

中文名称
——
中文别名
——
英文名称
R(-)-N-ethyl-2-(2-fluoroethoxy)-10-[(trifluoromethyl)sulfonyl]oxy-11-hydroxynoraporphine
英文别名
[(6aR)-6-ethyl-2-(2-fluoroethoxy)-11-hydroxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-10-yl] trifluoromethanesulfonate
R(-)-N-ethyl-2-(2-fluoroethoxy)-10-[(trifluoromethyl)sulfonyl]oxy-11-hydroxynoraporphine化学式
CAS
1264293-71-1
化学式
C21H21F4NO5S
mdl
——
分子量
475.461
InChiKey
BAJUBFQOYNPREP-MRXNPFEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    84.4
  • 氢给体数:
    1
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    R(-)-N-ethyl-2-(2-fluoroethoxy)-10-[(trifluoromethyl)sulfonyl]oxy-11-hydroxynoraporphine 在 palladium 10% on activated carbon ammonium acetate 、 magnesium 作用下, 生成 MCL-538 hydrochloride
    参考文献:
    名称:
    [EN] 2-ALKOXY-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF
    [FR] DÉRIVÉS DE 2-ALCOXY-11-HYDROXYAPORPHINE ET LEURS UTILISATIONS
    摘要:
    这项发明涉及选择性结合D2高亲和力受体的2-烷氧基-1-羟基吖啶衍生物。这些化合物可用于成像D2高亲和力受体以及用于治疗帕金森病、性功能障碍和抑郁症等疾病。
    公开号:
    WO2011130530A1
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors
    摘要:
    The 2-fluoroalkoxy-substituted catechol-aporphines 6, 8a-f and 11-mono-hydroxyaporphines 11a-e were synthesized and found to have high in vitro affinity and selectivity for the dopamine D-2 receptors. The catechol aporphines, 8b and 8d, and the monohydroxy aporphines, 11-ad, were identified as candidates for development as potential PET ligands.
    DOI:
    10.1021/ml1001689
点击查看最新优质反应信息

文献信息

  • 2-alkoxy-11-hydroxyaporphine derivatives and uses thereof
    申请人:The McLean Hospital Corporation
    公开号:US10081600B2
    公开(公告)日:2018-09-25
    The invention features 2-alkoxy-11-hydroxyaporphine derivatives that selectively bind D2high receptors. The compounds are useful for imaging D2high receptors and for the treatment of diseases, such as Parkinson's disease, sexual dysfunction, and depressive disorders.
    本发明具有选择性结合 D2high 受体的 2-烷氧基-11-羟基吗啡衍生物。这些化合物可用于 D2high 受体成像和疾病治疗,如帕金森病、性功能障碍和抑郁症。
  • 2-ALKOXY-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF
    申请人:Neumeyer John L.
    公开号:US20130209362A1
    公开(公告)日:2013-08-15
    The invention features 2-alkoxy-11-hydroxyaporphine derivatives that selectively bind D 2 high receptors. The compounds are useful for imaging D 2 high receptors and for the treatment of diseases, such as Parkinson's disease, sexual dysfunction, and depressive disorders.
  • US9517279B2
    申请人:——
    公开号:US9517279B2
    公开(公告)日:2016-12-13
  • Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D<sub>2</sub> Receptors
    作者:Anna W. Sromek、Yu-Gui Si、Tangzhi Zhang、Susan R. George、Philip Seeman、John L. Neumeyer
    DOI:10.1021/ml1001689
    日期:2011.3.10
    The 2-fluoroalkoxy-substituted catechol-aporphines 6, 8a-f and 11-mono-hydroxyaporphines 11a-e were synthesized and found to have high in vitro affinity and selectivity for the dopamine D-2 receptors. The catechol aporphines, 8b and 8d, and the monohydroxy aporphines, 11-ad, were identified as candidates for development as potential PET ligands.
  • [EN] 2-ALKOXY-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE 2-ALCOXY-11-HYDROXYAPORPHINE ET LEURS UTILISATIONS
    申请人:MCLEAN HOSPITAL CORP
    公开号:WO2011130530A1
    公开(公告)日:2011-10-20
    The invention features 2-alkoxy-l l-hydroxyaporphine derivatives that selectively bind D2high receptors. The compounds are useful for imaging D2high receptors and for the treatment of diseases, such as Parkinson's disease, sexual dysfunction, and depressive disorders.
    这项发明涉及选择性结合D2高亲和力受体的2-烷氧基-1-羟基吖啶衍生物。这些化合物可用于成像D2高亲和力受体以及用于治疗帕金森病、性功能障碍和抑郁症等疾病。
查看更多